Upstream Process Intensification for Virus Vaccine Manufacturing Case Study

Upstream Process Intensification for Virus Vaccine Manufacturing Case Study

Many viral manufacturing processes for animal health have been transferred from the time consuming and higher risk adherent culture systems to more scalable suspension cell cultures. Growing demand and the need for efficient and economic processes drive the continuous search for innovations. This talk describes studies conducted at MSD Animal Health to evaluate the XCell ATF® Technology for intensification of virus propagation on suspension cells.